Libya vs Maldives: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Libya
0.2%
in 2024
Maldives
0.2%
in 2024
Libya rank
78th
Maldives rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Libya
- Maldives
How they compare
Libya currently reports 0.2% against 0.2% in Maldives, a difference of 0.0%.
Across all 10 years both countries report, Maldives has been ahead every year.
Libya ranks 78th and Maldives ranks 78th of 215 countries.
Maldives has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Libya | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.4% | 0.2% | Maldives |
| 2020s | 0.2% | 0.2% | 0.0% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Libya or Maldives?
- Libya, at 0.2% against 0.2% in Maldives as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Libya and Maldives?
- 0.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Maldives?
- 10 years are reported by both, from 2015 to 2024.
- How do Libya and Maldives rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Libya ranks 78th and Maldives ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.